Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers

  • Salvat-Rovira, Nil|||0009-0005-8515-3819
  • Vázquez-Oliver, Anna|||0000-0002-9842-7656
  • Rivas Asensio, Elisa|||0009-0006-1645-0059
  • Herrero-Lorenzo, Marina|||0000-0003-2693-0700
  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Izquierdo, Cristina
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Martí, Eulàlia|||0000-0002-1030-3158
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pérez-González, Rocío|||0000-0002-0641-2001
Extracellular vesicles (EVs) in cerebrospinal fluid (CSF) represent a valuable source of biomarkers for central nervous system (CNS) diseases, offering new pathways for diagnosis and monitoring. However, existing methods for isolating EVs from CSF often prove to be labor-intensive and reliant on specialized equipment, hindering their clinical application. In this study, we present a novel, clinically compatible method for isolating EVs from CSF. We optimized the use of ExoGAG, a commercially available reagent that has been tested in plasma, urine and semen, and compared it directly with differential ultracentrifugation using Western blotting, protein quantification, nanoparticle tracking analysis, and cryogenic electron microscopy. Additionally, we analyzed the presence of specific microRNAs (miRNAs) known to be present in CSF-derived EVs. Our data demonstrate that ExoGAG is an effective method for isolating EVs from CSF, yielding a higher amount of EVs compared to traditional ultracentrifugation methods, and with comparable levels of specific miRNAs. In conclusion, the use of ExoGAG in a clinical setting may facilitate the testing of biomarkers essential for tracking brain pathology in CNS diseases.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structural brain correlates of dementia in Huntington's disease

  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Gómez Ansón, Beatriz|||0000-0001-7900-938X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Huntington's disease (HD) is a fatal genetic neurodegenerative disorder with no effective treatment currently available. Progressive basal ganglia and whole-brain atrophy and concurrent cognitive deterioration are prototypical aspects of HD. However, the specific patterns of brain atrophy underlying cognitive impairment of different severity in HD are poorly understood. The aim of this study was to investigate the specific structural brain correlates of major cognitive deficits in HD and to explore its association with neuropsychological indicators. Thirty-five symptomatic early-to-mild HD patients and 15 healthy controls (HC) with available T1-MRI imaging were included in this study. In this cross-sectional study, HD patients were classified as patients with (HD-Dem) and without (HD-ND) major cognitive impairment in the range of dementia. This classification was based on previously validated PD-CRS cutoff scores for HD. Differences in brain atrophy across groups were studied by means of grey-matter volume voxel-based morphometry (GMV-VBM) and cortical thickness (Cth). Voxelwise and vertexwise general linear models were used to assess the group comparisons, controlling for the effects of age, sex, education, CAG repeat length and severity of motor symptoms. Clusters surviving p < 0.05 and family-wise error (FWE) correction were considered statistically significant. In order to characterize the impact on cognitive performance of the observed brain differences across groups, GMV and Cth values in the set of significant regions were computed and correlated with specific neuropsychological tests. All groups had similar sociodemographic profiles, and the HD groups did not significantly differ in terms of CAG repeat length. Compared to HC, both HD groups exhibited significant atrophy in multiple subcortical and parietal brain regions. However, compared to HC and HD-ND groups, HD-Dem patients showed a more prominent pattern of reduced GMV and cortical thinning. Importantly, this thinning was restricted to regions of the parietal-temporal and occipital cortices. Furthermore, these brain alterations were further associated with poorer cognitive performance in tasks assessing frontal-executive and attention domains as well as memory, language and constructional abilities. Major cognitive impairment in the range of dementia in HD is associated with brain and cognitive alterations exceeding the prototypical frontal-executive deficits commonly recognized in HD. The observed posterior-cortical damage identified by MRI and its association with memory, language, and visuoconstructive dysfunction suggest a strong involvement of extra-striatal atrophy in the onset of severe cognitive dysfunction in HD patients. Critically, major cognitive impairment in this sample was not associated with CAG repeat length, age or education. This finding could support a possible involvement of additional neuropathological mechanisms aggravating cognitive deterioration in HD.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structure and Dynamics of Large-Scale Cognitive Networks in Huntington's Disease

  • Aracil-Bolaños, Ignacio|||0000-0002-8246-5025
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • González-de-Echávarri, José María|||0000-0002-6130-9111
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Izquierdo, Cristina
  • Gómez Ansón, Beatriz|||0000-0001-7900-938X
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Background: Huntington's disease is a neurodegenerative disorder characterized by clinical alterations in the motor, behavioral, and cognitive domains. However, the structure and disruptions to large-scale brain cognitive networks have not yet been established. Objective: We aimed to profile changes in large-scale cognitive networks in premanifest and symptomatic patients with Huntington's disease. Methods: We prospectively recruited premanifest and symptomatic Huntington's disease mutation carriers as well as healthy controls. Clinical and sociodemographic data were obtained from all participants, and resting-state functional connectivity data, using both time-averaged and dynamic functional connectivity, was acquired from whole-brain and cognitively oriented brain parcellations. Results: A total of 64 gene mutation carriers and 23 healthy controls were included; 21 patients with Huntington's disease were classified as premanifest and 43 as symptomatic Huntington's disease. Compared with healthy controls, patients with Huntington's disease showed decreased network connectivity within the posterior hubs of the default-mode network and the medial prefrontal cortex, changes that correlated with cognitive (t = 2.25, P = 0.01) and disease burden scores (t = -2.42, P = 0.009). The salience network showed decreased functional connectivity between insular and supramarginal cortices and also correlated with cognitive (t = 2.11, P = 0.02) and disease burden scores (t = -2.35, P = 0.01). Dynamic analyses showed that network variability was decreased for default-central executive networks, a feature already present in premanifest mutation carriers (dynamic factor 8, P = 0.02). Conclusions: Huntington's disease shows an early and widespread disruption of large-scale cognitive networks. Importantly, these changes are related to cognitive and disease burden scores, and novel dynamic functional analyses uncovered subtler network changes even in the premanifest stages.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Measuring the functional impact of cognitive impairment in Huntington's disease

  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Puig-Davi, Arnau|||0000-0001-8883-4947
  • Pagonabarraga Mora, Javier|||0000-0002-3248-704X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Background: Patients with Huntington's disease (HD) exhibit a variable predominance of cognitive, behavioral and motor symptoms. A specific instrument focusing on the impact of cognitive impairment in HD over functional capacity is lacking. Objective: To address the need for a brief and specifically developed HD questionnaire able to capture functional aspects suspected to be sensitive to cognitive impairment. Methods: We developed and validated the "Huntington's Disease-Cognitive Functional Rating Scale" (HD-CFRS) in 78 symptomatic carriers of the Huntington's disease mutation. We also administered the HD-CFRS to a knowledgeable informant to measure the level of agreement. To explore the association between HD-CFRS scores and participants' cognitive status, we administered objective measures of cognition. Participants were classified as cognitively preserved (HD-NC), as having mild cognitive impairment (HD-MCI), or as having dementia (HD-Dem). Results: The HD-CFRS showed concurrent validity and internal consistency in the three groups. HD carriers and informants in the HD-NC group obtained similar HD-CFRS scores. However, in patients with mild cognitive impairment and dementia, informers reported greater functional impairment than HD participants. The HD-CFRS total score showed strong correlations with measures assessing cognition. Conclusions: These findings support the utility of the HD-CFRS as a brief and reliable instrument to measure functional defects associated with cognitive impairment in HD. We believe this questionnaire could be a useful tool both for clinical practice and research.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease

  • Sampedro, Frederic|||0000-0002-3933-1355
  • Martínez-Horta, Saul|||0000-0003-0125-7249
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Pérez-González, Rocío|||0000-0002-0641-2001
  • Horta-Barba, Andrea|||0000-0003-0050-5466
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Aracil-Bolaños, Ignacio|||0000-0002-8246-5025
  • Gómez Ansón, Beatriz|||0000-0001-7900-938X
  • Kulisevsky, Jaime|||0000-0003-4870-1431
Female Huntington's disease (HD) patients have consistently shown a faster clinical worsening than male, but the underlying mechanisms responsible for this observation remain unknown. Here, we describe how sex modifies the impact of neurodegeneration on brain atrophy and clinical severity in HD. Cerebrospinal fluid neurofilament light chain (NfL) levels were used as a biological measure of neurodegeneration, and brain atrophy was assessed by structural magnetic resonance imaging. We found that larger NfL values in women reflect higher brain atrophy and clinical severity than in men (p < 0.05 for an interaction model). This differential vulnerability could have important implications in clinical trials.